Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Injection site erythema Reports for Pneumococcal (Pneumovax)
#1 most reported symptom for this vaccine
Injection site erythema and Pneumococcal (Pneumovax)
Injection site erythema has been reported 15,844 times in association with Pneumococcal (Pneumovax) vaccination in VAERS. This represents 22.3% of all 71,157 reports for this vaccine.
Among these reports, 5 mentioned death (0.03%) and 716 involved hospitalization (4.5%).
Injection site erythema is the #1 most frequently reported symptom for Pneumococcal (Pneumovax) out of 2065 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
What This Means
Seeing 15,844 reports of Injection site erythema after Pneumococcal (Pneumovax) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.03%, suggesting most cases are non-fatal.
Important Context
Similarly Ranked Symptoms
Quick Facts
Related Pages
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.